FDA’s Pazdur Tapped For New Oncology Office Director
This article was originally published in The Pink Sheet Daily
Executive Summary
Oncology division head Pazdur is selected to lead FDA’s new Office of Oncology Drug Products following national search. Pazdur will begin assuming duties of the office May 1; the office will officially launch in July as part of a broader Office of New Drugs reorganization.